Sentences with phrase «efficacy of immunotherapies in»

«This could be a universal mechanism for enhancing efficacy of immunotherapies in glioma,» she says.
Our objective is to use our microbiome therapeutic approach to improve the efficacy of immunotherapy in patients with life - threatening cancers.»

Not exact matches

Now, immunotherapy — a type of treatment that harnesses the patient's immune system to combat the disease — represents the future of cancer treatment, with its efficacy being demonstrated in even the most aggressive types of cancer.
Schlom, of the National Cancer Institute, says the next challenge for researchers is to find ways to combine different immunotherapy drugs into single treatments and measure their efficacy in clinical trials.
In a phase 1b clinical trial with 21 patients, researchers tested the safety and efficacy of combining the immunotherapy drug pembrolizumab with an oncolytic virus called T - VEC.
Dr. Gnjatic's research focuses on human antigen - specific immune responses to tumor antigens, in an attempt to define new targets for the development of cancer immunotherapies, assess the efficacy of these immunotherapies, and learn why they may fail.
«Our work has shown that overcoming brain tumor - induced immune suppression is critical for enhancing efficacy of anti-tumor immunotherapies,» says first author Neha Kamran, Ph.D., a U-M neurosurgery research fellow in the Castro / Lowenstein Lab.
«As we identify which bacteria have a similar effect in humans, it should be possible to develop probiotic supplements that specifically improve efficacy of immunotherapies,» he says.
The full paper that this statement is in response to can be found at: Niederberger et al. 2018 Safety and efficacy of immunotherapy with the recombinant B - cell epitope — based grass pollen vaccine BM32.
In the ensuing months, the two companies have published detailed, promising animal studies of their immunotherapies, including preclinical efficacy studies in animal models of human synucleinopathieIn the ensuing months, the two companies have published detailed, promising animal studies of their immunotherapies, including preclinical efficacy studies in animal models of human synucleinopathiein animal models of human synucleinopathies.
A range of immunotherapies are currently in use, yet their efficacy can be varied and differ from patient to patient.
Immune Design entered into a clinical trial collaboration with Genentech, a member of the Roche Group, to evaluate the safety and efficacy of its CMB305 cancer immunotherapy product candidate combined with the investigational cancer immunotherapy atezolizumab in a randomized Phase 2 trial in patients with soft tissue sarcoma.
a b c d e f g h i j k l m n o p q r s t u v w x y z